HPV vaccine initiation at 9 or 10 years of age and better series completion by age 13 among privately and publicly insured children in the US
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HPV vaccine initiation at 9 or 10 years of age and better series completion by age 13 among privately and publicly insured children in the US
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume -, Issue -, Pages -
Publisher
Informa UK Limited
Online
2023-01-12
DOI
10.1080/21645515.2022.2161253
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recommending Human Papillomavirus Vaccination at Age 9: A National Survey of Primary Care Professionals
- (2022) Wei Yi Kong et al. Academic Pediatrics
- Impact of the COVID-19 pandemic on pediatric and adolescent vaccinations and well child visits in the United States: A database analysis
- (2022) Stephanie A. Kujawski et al. VACCINE
- The Impact of the COVID-19 Pandemic on Immunization Campaigns and Programs: A Systematic Review
- (2021) Zohra S. Lassi et al. International Journal of Environmental Research and Public Health
- National and State-Specific Estimates of Settings of Receiving Human Papillomavirus Vaccination Among Adolescents in the United States
- (2021) Peng-jun Lu et al. JOURNAL OF ADOLESCENT HEALTH
- COVID-19 and vaccine hesitancy: A longitudinal study
- (2021) Ariel Fridman et al. PLoS One
- Impact of reduced human papillomavirus vaccination coverage rates due to COVID-19 in the United States: A model based analysis
- (2021) Vincent Daniels et al. VACCINE
- HPV vaccination uptake and administration from 2006 to 2016 in a commercially insured population of the United States
- (2021) Vimalanand S. Prabhu et al. BMC PUBLIC HEALTH
- Effect of Training Pediatric Clinicians in Human Papillomavirus Communication Strategies on Human Papillomavirus Vaccination Rates
- (2021) Peter G. Szilagyi et al. JAMA Pediatrics
- The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study
- (2021) Milena Falcaro et al. LANCET
- Human papillomavirus vaccination 2020 guideline update: American Cancer Society guideline adaptation
- (2020) Debbie Saslow et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Improving HPV Vaccination Rates: A Stepped-Wedge Randomized Trial
- (2020) Rebecca B. Perkins et al. PEDIATRICS
- Parental intent to initiate and complete the human papillomavirus vaccine series in the USA: a nationwide, cross-sectional survey
- (2020) Kalyani Sonawane et al. Lancet Public Health
- Trends in Human Papillomavirus Vaccination in Commercially Insured Children in the United States
- (2020) Szu-Ta Chen et al. PEDIATRICS
- Long-term effectiveness of the nine-valent human papillomavirus vaccine in Scandinavian women: interim analysis after 8 years of follow-up
- (2020) Susanne K. Kjaer et al. Human Vaccines & Immunotherapeutics
- Nine-valent HPV vaccine efficacy against related diseases and definitive therapy: comparison with historic placebo population
- (2019) Anna R. Giuliano et al. GYNECOLOGIC ONCOLOGY
- Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study
- (2019) Tim Palmer et al. BMJ-British Medical Journal
- Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis
- (2019) Mélanie Drolet et al. LANCET
- Provider Experience Recommending HPV Vaccination Before Age 11 Years
- (2019) Dea L. Biancarelli et al. JOURNAL OF PEDIATRICS
- Quality Improvement Initiative to Improve HPV Vaccine Initiation at Nine Years of Age ,,
- (2018) Martha J. Goleman et al. Academic Pediatrics
- Predictors of Human Papillomavirus Vaccine Follow-Through Among Privately Insured US Patients
- (2018) Jennifer C. Spencer et al. AMERICAN JOURNAL OF PUBLIC HEALTH
- Worldwide burden of cancer attributable to HPV by site, country and HPV type
- (2017) Catherine de Martel et al. INTERNATIONAL JOURNAL OF CANCER
- Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial
- (2017) Warner K Huh et al. LANCET
- Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience
- (2016) Suzanne M. Garland et al. CLINICAL INFECTIOUS DISEASES
- Immunogenicity of the 9-Valent HPV Vaccine Using 2-Dose Regimens in Girls and Boys vs a 3-Dose Regimen in Women
- (2016) Ole-Erik Iversen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Younger age at initiation of the human papillomavirus (HPV) vaccination series is associated with higher rates of on-time completion
- (2016) Jennifer L. St. Sauver et al. PREVENTIVE MEDICINE
- Factors related to HPV vaccine uptake and 3-dose completion among women in a low vaccination region of the USA: an observational study
- (2016) Andrew R. Wilson et al. BMC Womens Health
- Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis
- (2016) Laia Bruni et al. Lancet Global Health
- Use of a 2-Dose Schedule for Human Papillomavirus Vaccination — Updated Recommendations of the Advisory Committee on Immunization Practices
- (2016) Elissa Meites et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Using Medical Claims for Policy Effectiveness Surveillance: Reimbursement and Utilization of Abdomen/Pelvis Computed Tomography Scans
- (2015) Michal Horný et al. HEALTH SERVICES RESEARCH
- Timing of HPV vaccine intervals among United States teens with consideration to the current ACIP schedule and the WHO 2-dose schedule
- (2015) Emily A. Cloessner et al. Human Vaccines & Immunotherapeutics
- Race, Ethnicity, and Income Factors Impacting Human Papillomavirus Vaccination rates
- (2014) Patricia Jeudin et al. CLINICAL THERAPEUTICS
- The influence of free quadrivalent human papillomavirus vaccine (HPV4) on the timely completion of the three dose series
- (2014) Diane M. Harper et al. PREVENTIVE MEDICINE
- Factors Associated With Medicaid Providers' Recommendation of the HPV Vaccine to Low-Income Adolescent Girls
- (2013) Shalanda A. Bynum et al. JOURNAL OF ADOLESCENT HEALTH
- Values and Pitfalls of the Use of Administrative Databases for Outcomes Assessment
- (2013) Emilie K. Johnson et al. JOURNAL OF UROLOGY
- Predictors of Three Dose On-Time Compliance with HPV4 Vaccination in a Disadvantaged, Underserved, Safety Net Population in the US Midwest
- (2013) Inge Verdenius et al. PLoS One
- Barriers to Human Papillomavirus Vaccination Among US Adolescents
- (2013) Dawn M. Holman et al. JAMA Pediatrics
- The HPV vaccine: Are dosing recommendations being followed?
- (2011) Weiyi Tan et al. VACCINE
- Compliance with recommended dosing intervals for HPV vaccination among females, 13–17 years, National Immunization Survey-Teen, 2008–2009
- (2011) Christina G. Dorell et al. VACCINE
- Long-term persistence of systemic and mucosal immune response to HPV-16/18 AS04-adjuvanted vaccine in preteen/adolescent girls and young women
- (2010) Tiina Petäjä et al. INTERNATIONAL JOURNAL OF CANCER
- Adherence to the HPV Vaccine Dosing Intervals and Factors Associated With Completion of 3 Doses
- (2010) L. E. Widdice et al. PEDIATRICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started